VelaLabs GmbH, a leading provider of analytical and quality services for biopharmaceutical development, has signed a Memorandum of Understanding (MoU) with EarlyHealth Group to establish comprehensive solutions for the development of advanced biological drugs. The partnership brings together the strengths of both companies in streamlining biological drug development and providing end-to-end support, from early product […]
continue reading
The global focus on green agrochemistry and the health of consumers and operators continues to grow, driving significant changes in the regulation of agrochemicals. Agrochemicals are increasingly subject to recertification as new regulations are introduced annually. Even long-established products must now provide updated impurity data, often with stricter limits than before. A notable example includes […]
continue reading
EPL Bio Analytical Services, a Tentamus company, is excited to announce a partnership with our German sister lab EpiLogic GmbH to bring EpiLogic’s industry leading plant fungal pathogen testing services to North America. EpiLogic GmbH is specialized in applied phytopathology and related studies on the adaptation and resistance of fungal pathogens to fungicides. With studies […]
continue reading
Tentaconsult blickt auf einen äußerst erfolgreichen Auftritt auf der MEDICA 2024 zurück. Als Teil des Gemeinschaftsstands der Bayern Innovativ GmbH nutzte das Unternehmen die internationale Fachmesse, um sich mit führenden Akteuren der Branche auszutauschen und neue Impulse für die Zukunft des Gesundheitswesens zu sammeln. „Für uns war die MEDICA 2024 mehr als nur eine repräsentative […]
continue reading
Tentamus QTS Analytical is excited to announce a major advancement in our pesticide analysis services, reinforcing our commitment to safety and quality for the British fresh produce industry. Through a strategic collaboration with LECO, we’ve acquired cutting-edge equipment capable of detecting even trace-level pesticide residues. This new capability offers our clients highly sensitive and accurate […]
continue reading
The Tentamus Group is excited to announce the appointment of Richard Adams as CEO of Tentamus North America, effective from November 1, 2024. With North America representing the second-largest region within the Tentamus Network and a crucial driver of our future growth, Richard’s leadership comes at an opportune time for our expansion in the region. […]
continue reading
The Tentamus Group is pleased to announce its acquisition of CardioMed Device Consultants, LLC, a leading provider of consulting services in the medical device industry, with a specialized focus on cardiovascular devices. This strategic acquisition broadens Tentamus’ service portfolio by adding regulatory and pre-clinical consulting services, further solidifying its expertise in the cardiovascular device sector, […]
continue reading
Wir freuen uns, bekanntzugeben, dass Frau Heinke Bock ab dem 15. Oktober 2024 die Position der Chief Human Resources Officer (CHRO) der Tentamus Group übernehmen und Mitglied des Group Executive Teams werden wird. Frau Bock wird direkt an Dr. Christian Rebhan, CEO der Tentamus Group, berichten. In dieser Rolle wird Frau Bock die Verantwortung für […]
continue reading
We are pleased to announce that effective October 15th 2024, Ms. Heinke Bock will become Chief Human Resources Officer (CHRO) of Tentamus Group and a member of the Group Executive Team. Ms. Bock will report directly into Dr. Christian Rebhan, CEO of the Tentamus Group. In this role, Ms. Bock will be responsible for further […]
continue reading
The Tentamus Group is pleased to welcome Dr. Hummert as the new Country Manager for the DACH region starting on October 1, 2024. With his extensive experience and long-standing expertise in the food and agricultural sectors, he will play a crucial role in advancing the Tentamus Group in the region. Christian Hummert boasts an impressive […]
continue reading